NR4A2 and esophageal squamous cell carcinoma: Indeed, treatment of ESCC cells with a global methylation inhibitor, 3-deazaadenosine (DAA), substantially declined methionine and SAM-induced NR4A2 expression at both the mRNA and protein levels (Fig. 5C, D, Supplementary Fig. S6B, C).